echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Elite program of pharmaceutical Intelligence Consulting - expert recruitment

    Elite program of pharmaceutical Intelligence Consulting - expert recruitment

    • Last Update: 2019-10-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Relying on the powerful pharmaceutical industry data platform, the top-level expert resources and professional and efficient consulting team, Pharma Consulting provides customers with in-depth and insightful consulting services and personalized solutions, including due diligence, drug project approval, market research, product screening, patent analysis, project resource integration and other professional services Since the establishment of the team, it has successfully served more than 100 institutions at home and abroad, including CDE, Taiji group, Otsuka pharmaceutical, etc., and has been highly recognized and widely praised by customers In order to gather excellent resources in the industry and create an exchange platform for industry elite talents, pharma.com invites experts from the pharmaceutical industry to talk about hot topics in the pharmaceutical industry and discuss the development direction of China's pharmaceutical industry More than 10 visiting experts, including Hou Yu, Meng Bayi, Tang Huadong, Wang Gang and Su min, have joined the visiting expert team of pharma You will be able to discuss the development of China's pharmaceutical industry with the existing expert team of pharma.com Introduction to experts: Professor Hou Yu, chief expert of yaozhi.com, former director of science and Technology Information Research Institute of Hebei University of science and technology, has been engaged in the field of pharmaceutical and chemical information for more than 20 years, supported the completion of more than 20 scientific research projects, 6 national patents, and published more than 50 papers Domestic senior experts in the field of pharmaceutical database construction, participate in the construction and development of pharmaceutical intelligence data He also serves as the R & D consultant of many domestic pharmaceutical and chemical industries, and has rich experience in the training of pharmaceutical information skills, the construction of information support system and the screening and demonstration of target pharmaceutical projects Meng Bayi, senior consultant, master of pharmaceutical chemistry, Academy of Military Medical Sciences, New York City University, master of computer science He used to be the patent agent of China Patent Agency (Hong Kong) Co., Ltd.; from 2004 to 2015, he worked in Chongqing Huabang Pharmaceutical Co., Ltd., responsible for intellectual property, it, API export, etc., and had five years of IT industry experience in the United States He has rich experience in European and American policies and regulations, drug research and development, patent application, intellectual property analysis and risk aversion Tang Huadong, Ph.D lawyer, graduated from China University of political science and law and Tsinghua University with a master's degree in law and a doctor's degree in science He has successively served as the patent examination center of the State Intellectual Property Office, partner of Beijing Zhide law firm, CEO of Beijing Huizhi Tiancheng intellectual property agency, etc He is proficient in medicine, law, intellectual property and other aspects of knowledge, and has rich experience in non litigation, litigation and dispute resolution in the fields of medical health, chemistry, materials and life sciences Wang Gang, deputy director, associate professor of pharmacist, master's supervisor He has been engaged in clinical pharmacology research and clinical drug evaluation for a long time He served as the standing editorial board member of Chinese Journal of modern medicine and Journal of Pediatrics He has published more than 80 research works, 6 of which are included in SCI, and participated in the compilation of 12 academic monographs He has presided over a number of national science and research projects and won 4 provincial and ministerial awards for scientific and technological achievements Dr Su min, Ph.D., professor He has successively worked in Chongqing University, Chongqing Institute of traditional Chinese medicine and other pharmaceutical research institutions, and now he is the Third Military Medical University, and concurrently serves as nmpa drug and food review expert, as well as review expert of science and technology projects in Chongqing, Tianjin, Guangdong, Hebei and other places Presided over and completed 3 provincial and ministerial scientific research projects, undertook 3 national new drug development and military special drug development projects; nearly 30 new drug and generic drug projects; participated in the preparation of the Ministry of education's "pharmaceutics" planning textbook; owned several invention patents Some cases of pharmaceutical intelligence consulting show: Industry Research Report: completed the project research (project demonstration, Market Research) of China Pharmaceutical internationalization Research Report entrusted by China Pharmaceutical Enterprise Management Association: completed the data processing, system construction and information retrieval of product screening service with Chinese market prospect entrusted by a leading foreign generic pharmaceutical enterprise: To complete the project service and patent service for the CDE network platform construction project of "China listed drug catalog set": to complete the patent analysis report of a drug entrusted by the pharmaceutical factory of China Pharmaceutical University; to join the visiting expert team of pharmaceutical intelligence consulting, you will enjoy the following rights and interests: 1) If you participate in the project, you will enjoy the same Commission treatment as the in-service team of Yaozhi; 2) Contribution fee of works; 2) free access to some databases (open according to the needs of the project); 3) lecturer courses of the Institute of pharmaceutical intelligence; 4) participation in meetings held by the website of pharmaceutical intelligence; 5) irregular opportunities for industry experts to exchange; 6) personal interview reports of pharmaceutical intelligence media to create personal image; 7) presentation of "40 years of big data of Chinese pharmaceutical research and development" At the same time, in order to strengthen the cooperation between the two sides, you will also assume the following responsibilities: 1 sign a confidentiality agreement; 2 submit a quarterly industry related contribution; 3 participate in project tasks, provide assistance and support; registration method: send personal resume, works (no limit in form) to email or WeChat email: suntao@yaozh.com WeChat: WGPPping contact phone: 13271830213 Click on the following link to see more details: https://zx.yaozh.com/? Yaozh this recruitment plan is valid for a long time.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.